Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Beyond beta blockers

Nature Medicine volume 11, pages 379–380 (2005)Cite this article

Blocking β-adrenergic receptors is a standard treatment for heart failure, but it limits the normal ability to modulate cardiac function. Targeting therapy further downstream by blocking activation of calcium-calmodulin–dependent protein kinase could provide an alternative (pages 409–407).

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: CaMKII in cardiac myocytes.

Katherine Ris

References

  1. Zhang, R. et al. Nat. Med. 446–449 (2005).

  2. Hoch, B., Meyer, R., Hetzer, R., Krause, E.G. & Karczewski, P. Circ. Res. 84, 713–721 (1999).

    Article  CAS  Google Scholar 

  3. Zhang, T. et al. Circ. Res. 92, 912–916 (2003).

    Article  CAS  Google Scholar 

  4. Zhang, T. et al. J. Biol. Chem. 277, 1261–1267 (2002).

    Article  CAS  Google Scholar 

  5. Maier, L.S. et al. Circ. Res. 92, 904–911 (2003).

    Article  CAS  Google Scholar 

  6. Wu, Y. et al. Circulation 106, 1288–1293 (2002).

    Article  CAS  Google Scholar 

  7. Yuan, W. & Bers, D.M. Am. J. Physiol. 267, H982–H993 (1994).

    CAS  PubMed  Google Scholar 

  8. Dzhura, I., Wu, Y., Colbran, R. J. & Anderson, M. E. Nat. Cell Biol. 2,: 173–177 (2000)

    Article  CAS  Google Scholar 

  9. Wehrens, X.H., Lehnart, S.E., Reiken, S.R. & Marks, A.R. Circ Res. 94, e61–e70 (2004).

    Article  CAS  Google Scholar 

  10. Li, L., Satoh, H., Ginsburg, K.S. & Bers, D.M. J. Physiol. 501, 17–31 (1997).

    Article  CAS  Google Scholar 

  11. Pogwizd, S.M., Schlotthauer, K., Li, L., Yuan, W., Bers, D.M. Circ. Res. 88, 1159–1167 (2001).

    Article  CAS  Google Scholar 

  12. McKinsey, T.A., Zhang, C.L. & Olson, E.N. Proc. Natl. Acad. Sci. USA 97, 14400–14405 (2000).

    Article  CAS  Google Scholar 

  13. Wu, X. et al. Circulation 110, III-285 (2004).

    Article  Google Scholar 

  14. Wang, W. et al. Circ. Res. 95, 798–806 (2004).

    Article  CAS  Google Scholar 

  15. Bare, D.J., Kettlun, C.S., Liang, M., Bers, D.M., Mignery, G. A et al. J. Biol. Chem. published online 13 February 2005 (10:1074/jbc.M41421200).

Download references

Author information

Authors and Affiliations

  1. Department of Physiology, Stritch School of Medicine, Loyola University Chicago, Maywood, 60153, Illinois, USA

    Donald M Bers

Authors
  1. Donald M Bers
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bers, D. Beyond beta blockers. Nat Med 11, 379–380 (2005). https://doi.org/10.1038/nm0405-379

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0405-379

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing